{"nct_id":"NCT05063565","title":"TheraSphere With Durvalumab and Tremelimumab for HCC","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2023-11-03","start_date_type":"ACTUAL","primary_completion_date":"2027-06","primary_completion_date_type":"ESTIMATED","completion_date":"2027-06","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["BSX"]}